Abtak Logo

ovarian-cancer News

Stay updated with the latest ovarian-cancer news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on ovarian-cancer topics.

NewsDrum - Politics - News Image
soure image
15
PoliticsApr 06, 2026 03:18 PM

Delhi court adjourns hearing on Siddiqui'€™s fresh interim bail plea to April 11

New Delhi, Apr 6 (PTI) A Delhi court on Monday deferred the hearing of arguments on the fresh interim bail application filed by Al-Falah group chairman Jawad Ahmad Siddiqui to April 11. This plea is related to the money laundering case involving the cheating of students enrolled in the Al-Falah University. Additional Sessions Judge Sheetal Chaudhary Pradhan was hearing the fresh bail plea after it was remanded to trial court by the Delhi High Court on April 1. Earlier on Wednesday, the Delhi ...Read More >

Abtak.com - Health - News Image
soure image
28
HealthDec 15, 2025 06:39 PM

Chinese researchers publish major clinical study on ovarian cancer

A major Chinese clinical study on ovarian cancer has been published in CA: A Cancer Journal for Clinicians, one of the world's highest-impact medical journal, marking a first for a Chinese researcher-led gynecological cancer trial, researchers said in Beijing on Sunday. The phase III FZOCUS-1 study tested fluzoparib, a PARP inhibitor developed by Chinese pharmaceutical giant Hengrui Pharma. The trial evaluated the drug as a "maintenance" therapy, treatment given to prevent cancer recurrence aft ...Read More >

NewsDrum - Health - News Image
soure image
10
HealthOct 23, 2025 05:23 AM

Study shows less than 20 pc of women in low and middle-income countries diagnosed with cancer at ear...

New Delhi, Oct 23 (PTI) Under a fifth of women in low and middle-income countries having breast or cervical cancer are diagnosed at an early stage, compared to two in every five in high-income countries, according to a study published in The Lancet journal, highlighting disparities in cancer care around the world. Too many women, especially in low and middle-income countries, are only diagnosed when their cancer is already advanced, reducing their chances of survival compared to women in wealth ...Read More >

News18 - Health - News Image
soure image
36
HealthSep 16, 2025 04:04 PM

Nafisa Ali Sodhi resumes chemotherapy, shares emotional post on social media

New Delhi, Sep 16 (PTI) Veteran actor and politician Nafisa Ali Sodhi on Tuesday shared a new update in her cancer battle, saying that she is resuming chemotherapy after undergoing a PET scan. Sodhi has been battling stage-three peritoneal and ovarian cancer since 2018. After the scan, doctors have ruled out surgery as an option. Sodhi shared a quote in her Instagram post which read, "'Who will we turn to when you're gone?' I told them, 'Turn to each other. That is my greatest gift- siblings w ...Read More >

fallback-img
soure image
4
BusinessJul 01, 2025 09:34 AM

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Doxorubicin Hydrochloride Liposom...

Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxorubicin Hydrochloride Liposome Injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Doxil Liposome Injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL), of Baxter Health ...Read More >

NewsDrum - Business - News Image
soure image
21
BusinessJun 30, 2025 12:34 PM

Alembic Pharmaceuticals gets USFDA nod for generic cancer treatment injection

New Delhi, Jun 30 (PTI) Alembic Pharmaceuticals on Monday said it has received the final approval from the US health regulator for its generic Doxorubicin Hydrochloride Liposome injection in different types of cancer. The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) is for Doxorubicin Hydrochloride Liposome injection of strengths 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials, Alembic Pharmaceuticals said in a statement ...Read More >

NewsDrum - Health - News Image
soure image
HealthMay 27, 2025 02:43 PM

Warmer climate could be making cancer among women more common, study says

New Delhi, May 27 (PTI) Global warming could be making cancer in women more common and deadly, according to a study conducted in the Middle East and North Africa. The region is predicted to reach three to four degrees Celsius of warming about three decades earlier than the rest of the world. Summers in Middle Eastern nations, such as the United Arab Emirates, are characterised by extremely high temperatures - sometimes touching 50 degrees Celsius -- while North Africa sees temperatures in the ...Read More >

The Times of India - Entertainment - News Image
soure image
11
EntertainmentNov 27, 2024 01:39 PM

We Live in Time Review: Andrew Garfield and Florence Pugh deliver powerful performances in a film th...

Story: This film traces the poignant journey of Tobias and Almut's relationship over a decade, beginning with a life-changing moment when Tobias is injured in an accident caused by Almut's car. Review: 'We Live in Time' is an intensely moving story of a couple deeply in love, brought to life by the exceptional performances of Andrew Garfield and Florence Pugh. Their portrayals draw you into the emotional highs and lows of their journey, making you empathize with their joys and heartbreaks. The ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.